Researchers reconstruct SARS-CoV-2 evoluti...British researchers have tabled a phylogenetic tree showing different subtypes of SARS-CoV-2 developed in Asia, Europe and the US. more ➔
COVID-19: Solnatide approved for compassio...Austrian COVID-19 patients with severe lung dysfunction for the first time have a treatment option within a compassionate use program for Apeptico’s solnatide. more ➔
GE renamed Cytiva upon take-over by Danahe...Following the completion of Danahers €19.5bn take-over of GE Healthcare Life Sciences, GEs CDMO arm is renamed Cytiva. more ➔
Making opoids more effective pain killersLow intrinsic efficacy can explain the reduced side effects of new agonists of the m-opioid receptor a British-Australian reseach team reports. more ➔
Apeptico gets EU grant for COVID-19 drugAustrian APEPTICO has got Horizon 2020 money for accelerated development and clinical use of Solnatide for the treatment of COVID-19 patients more ➔
CHMP greenlights Novartis ZolgensmaThe European Medicines Agency EMA has backed eight medicines for approval at its virtual March 2020 meeting. more ➔
New resource models human metabolismScandinavian researchers have created a unified, open-source model providing a genome-wide portrait of human disease metabolism. more ➔
Novacyt inks contract on Covid-19 diagnost...Paris-based Novacyt SA has signed a global distribution agreement with Bruker Ltd for its COVID-19 diagnostic test. more ➔
AC Immune SA gets Lilly milestone for Alzh...AC Immune SA has received a milestone payment of CHF10m from Eli Lilly and Company. more ➔
Experts discuss link between sepsis and Co...Scientists have discussed a link between Covid-19 and sepsis at a virtual symposium at Charité Berlin that might help reduce the burden of end-stage disease. more ➔
